Clinical and pathological implications of miRNA in bladder cancer - Wikidata - awgldk - TriplyDB

Clinical and pathological implications of miRNA in bladder cancer

Clinical and pathological implications of miRNA in bladder cancer

http://www.wikidata.org/entity/Q27004262

about

Circulating MicroRNAs as Biomarkers in Biliary Tract Cancers MicroRNA aberrations: An emerging field for gallbladder cancer management Formononetin inhibits human bladder cancer cell proliferation and invasiveness via regulation of miR-21 and PTEN.MicroRNAs as biomarkers associated with bladder cancer.MicroRNA-608 inhibits proliferation of bladder cancer via AKT/FOXO3a signaling pathway Future trends and emerging issues for nanodelivery systems in oral and oropharyngeal cancer The fascinating story of urine examination: From uroscopy to the era of microscopy and beyond.MicroRNA molecular profiling from matched tumor and bio-fluids in bladder cancer.Repression of the miR-93-enhanced sensitivity of bladder carcinoma to chemotherapy involves the regulation of LASS2.c-Met and CREB1 are involved in miR-433-mediated inhibition of the epithelial-mesenchymal transition in bladder cancer by regulating Akt/GSK-3β/Snail signaling.Normalization of gene expression measurement of tissue samples obtained by transurethral resection of bladder tumors MicroRNA-206 acts as a tumor suppressor in bladder cancer via targeting YRDC.Genome-Wide Screen of miRNAs and Targeting mRNAs Reveals the Negatively Regulatory Effect of miR-130b-3p on PTEN by PI3K and Integrin β1 Signaling Pathways in Bladder Carcinoma.Computational identification of microRNAs associated to both epithelial to mesenchymal transition and NGAL/MMP-9 pathways in bladder cancer.miR-202 inhibits the progression of human cervical cancer through inhibition of cyclin D1.The upregulation of miRNA-146a inhibited biological behaviors of ESCC through inhibition of IRS2.Understanding the Role of Non-Coding RNAs in Bladder Cancer: From Dark Matter to Valuable Therapeutic Targets.Circulating microRNAs, miR-92a, miR-100 and miR-143, as non-invasive biomarkers for bladder cancer diagnosis.Sensitive detection of microRNAs based on the conversion of colorimetric assay into electrochemical analysis with duplex-specific nuclease-assisted signal amplification.miR-204 suppresses the development and progression of human glioblastoma by targeting ATF2.The new era of nanotechnology, an alternative to change cancer treatment.Evaluation of the NMP22 BladderChek test for detecting bladder cancer: a systematic review and meta-analysis.miRNA expression profiling in formalin-fixed paraffin-embedded endometriosis and ovarian cancer samples.Effects of microRNA-135a on the epithelial-mesenchymal transition, migration and invasion of bladder cancer cells by targeting GSK3β through the Wnt/β-catenin signaling pathway.Implications of dietary ω-3 and ω-6 polyunsaturated fatty acids in breast cancer.MiR-22 suppresses epithelial-mesenchymal transition in bladder cancer by inhibiting Snail and MAPK1/Slug/vimentin feedback loop.The Unforeseen Non-Coding RNAs in Head and Neck Cancer.Tumor-suppressing effects of microRNA-612 in bladder cancer cells by targeting malic enzyme 1 expression.The Clinical Relevance of Fragile Histidine Triad Protein (FHIT) in Patients with Bladder Cancer.RNA interference: new mechanistic and biochemical insights with application in oral cancer therapy.Urinary Markers in Bladder Cancer: An Update MicroRNA-325 Is a Potential Biomarker and Tumor Regulator in Human Bladder Cancer

P2860

Q26746000-A76BA4F3-2AF8-451B-9ED2-7BE085C89925 Q26768416-2FA45184-F2E6-4EF5-BBA7-B5DE9C986CDB Q32182546-F96D80D0-8C1F-471A-AE16-3A08348015B1 Q33642335-2EEAF343-E4D3-4CE3-8520-215E081F1891 Q33733659-16168801-BD83-41F3-8DA0-7C110A5E575D Q33881254-1A8AB29E-9F0C-49B6-90E1-686CCD5C2B24 Q35782652-3350242C-2063-45D7-9E97-A40BAD4791B7 Q36294474-F742F980-C685-4C70-8157-8A5859BE51A9 Q36766823-27A9908F-B5D6-45ED-B5B9-29CED21987DB Q36847509-F2CFDA75-7C8C-4AF2-B142-7E9719C9765B Q36982267-FE9DCD35-9564-4D7D-A5AE-35782D5D4B7B Q37448112-BFBA33E4-EFF5-40AB-AB08-825EFEC0C852 Q37631494-73F56CAC-35D1-492D-9A01-D036B0E8F62B Q37687288-84639CB5-0BC9-4A1B-B6F2-778E702DD177 Q37687775-DFC54A69-8CD9-42AA-AB77-730D393FE209 Q38824321-F0DF37D2-DCF7-4611-9CC6-8FDF8D3EE168 Q39432577-A7B6CFEC-F8B6-4F6F-B1DE-4D9433ADD902 Q39967840-E003BA9C-99D5-4530-969F-4129532A9A43 Q41057545-C75004E8-611C-479B-8F7E-35CEA1BEFCF1 Q42173629-EC18F787-DDDA-41D5-80CD-58027146FBAE Q42370576-A0AF84F2-AE09-49F6-B809-8693543A5A4E Q47281870-5892338B-CC24-4923-A1AF-CBFEF86A2F8F Q48000348-FB4A8864-B0A6-4D2B-9D92-27E3F2483D53 Q49922976-D23527FE-9B3C-4021-999A-6AFD7D2ADA32 Q50054220-0B6C0655-E085-41BB-95DE-BE860DB933A3 Q50055664-FFC28FC9-5253-455D-8CFC-25AD5E1DE330 Q52729619-AF397548-9ADB-4E89-84C6-307A97ACB5D8 Q54981235-15D4A7A4-F92E-46DA-9356-183400E5C871 Q55072176-E32D6EA0-FD5E-4575-B37C-CA60C54DE4FF Q55360697-C5F48711-29F6-4F82-9C6D-5CBB41E03B71 Q58758892-B6BE22B6-5640-474A-A6FB-29BAB51B4815 Q58768900-0A7E71B8-FE17-426A-97C6-A5B7590A1B72

P2860

Clinical and pathological implications of miRNA in bladder cancer

http://www.wikidata.org/entity/Q27004262

description

2015 nî lūn-bûn

@nan

2015 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Clinical and pathological implications of miRNA in bladder cancer

@ast

Clinical and pathological implications of miRNA in bladder cancer

@en

Clinical and pathological implications of miRNA in bladder cancer

@nl

type

label

Clinical and pathological implications of miRNA in bladder cancer

@ast

Clinical and pathological implications of miRNA in bladder cancer

@en

Clinical and pathological implications of miRNA in bladder cancer

@nl

prefLabel

Clinical and pathological implications of miRNA in bladder cancer

@ast

Clinical and pathological implications of miRNA in bladder cancer

@en

Clinical and pathological implications of miRNA in bladder cancer

@nl

P1433

Q27004262-CD3CCDF1-767E-48B3-9778-ABAC77EA7C13

P1476

Q27004262-1D3AC41B-823E-4B64-AF6D-D700C1A4B8CD

P2093

Q27004262-77E9548A-86CC-4CFE-A2E4-B191EBC363DB

Q27004262-78F7B079-94B4-4C81-9328-53B83D08EA65

Q27004262-7F526CDC-31C8-478D-8A08-884A3DB29254

Q27004262-82826143-65A3-4F3C-9F12-CC75A4DEB531

Q27004262-B64E1784-EB3D-4691-BAA0-FBED4B892E98

Q27004262-DA4DFC6D-6F7A-4FD4-9B18-C418EC80CCF6

Q27004262-E73E6204-3ADC-4FCD-BEE9-5FFBFE7071A2

Q27004262-E8C4ADCB-9C33-441F-9509-B8AAD91161A2

P275

Q27004262-6A60814B-D2FE-4EA1-9DF0-849EA48FF611

P2860

Q27004262-00B475AA-C835-4EAA-A55E-24678FD62E9E

Q27004262-10B5468D-3143-4499-B452-A364896BB8FF

Q27004262-2407769A-8808-48C5-AF8E-6ADDEDEE098C

Q27004262-272E53E3-B1FF-437B-9E94-D5D64D5C86D0

Q27004262-293041EC-8108-4CE8-838F-E66696E910C5

Q27004262-373C4192-97B3-4D91-8C7D-FE7FAB0754CA

Q27004262-3F25DA85-CD90-488B-BCD5-AF6E369408D4

Q27004262-4450B9EB-6210-40F9-AD05-C7A53EEEB5E8

Q27004262-54AF2C37-EFC4-401B-B96D-C3F5FC3E33F9

Q27004262-5A400DD6-2F32-4431-925D-D9255E187DB6

P304

Q27004262-3373D9C4-80C9-46D0-9A79-5ED7562607FB

P31

Q27004262-BBEDF89A-77B0-40F9-A0A5-266103176EA4

Q27004262-C91F49F2-318F-4B4E-82AB-BC2A34CF7071

P3181

Q27004262-D18AB89D-5288-4F61-B55F-BE4C0E2229E0

P356

Q27004262-FB4B5335-96C8-4EF9-881D-AD85AD4916CA

P407

Q27004262-441B0ABF-486F-4CBF-81FD-69C7BF6ABBDA

P478

Q27004262-C53AAAFA-FDC8-4020-A018-6950A2543A60

P5008

Q27004262-4CDA2B06-50A2-40BE-97B3-26A0648AF397

P577

Q27004262-48E83D2F-3036-428B-B635-41416AC2EC07

Q27004262-71875464-D8E7-4ECE-B819-087029B9F7C9

P698

Q27004262-B6C1569B-B7B9-4A7E-AC27-BA721864A429

P921

Q27004262-0BAF7501-B75F-4FCF-8D6B-741F9FFEAB18

Q27004262-907DB2F2-0176-4DC3-9AEC-7D01F3423B61

Q27004262-b68d5908-4bf9-2f43-8efd-4bd9bc5b5b30

P932

Q27004262-A951B3BE-B737-4E7A-9647-640BAD61BCCF

P3181

P356

P1433

International Journal of Nanomedicine

P1476

Clinical and pathological implications of miRNA in bladder cancer

@en

P2093

Alexandru Floares

http://www.w3.org/2001/XMLSchema#string

Anamaria Truta

http://www.w3.org/2001/XMLSchema#string

Bogdan Petrut

http://www.w3.org/2001/XMLSchema#string

Cornelia Braicu

http://www.w3.org/2001/XMLSchema#string

Ioana Berindan-Neagoe

http://www.w3.org/2001/XMLSchema#string

Patriciu Achimas-Cadariu

http://www.w3.org/2001/XMLSchema#string

Roxana Cojocneanu-Petric

http://www.w3.org/2001/XMLSchema#string

Sergiu Chira

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial

P2860

Wnt signaling pathways in urological cancers: past decades and still growing

Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma

Causes and consequences of microRNA dysregulation in cancer

The microRNA spectrum in 12 body fluids

Human microRNA oncogenes and tumor suppressors show significantly different biological patterns: from functions to targets.

Distinct microRNA alterations characterize high- and low-grade bladder cancer

MicroRNA expression signatures of bladder cancer revealed by deep sequencing.

Coordinated epigenetic repression of the miR-200 family and miR-205 in invasive bladder cancer.

miR-143, miR-222, and miR-452 are useful as tumor stratification and noninvasive diagnostic biomarkers for bladder cancer.

microRNA expression profile in a large series of bladder tumors: identification of a 3-miRNA signature associated with aggressiveness of muscle-invasive bladder cancer.

P304

791-800

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1092216

http://www.w3.org/2001/XMLSchema#string

P356

10.2147/IJN.S72904

http://www.w3.org/2001/XMLSchema#string

P407

P478

10

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2015-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2015-01-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25653521

http://www.w3.org/2001/XMLSchema#string

P921

regulation of gene expression

bladder neoplasm

neoplastic gene expression regulation

P932

4309789

http://www.w3.org/2001/XMLSchema#string